Position in CERS
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$172,162
-$298,471 QoQ
Shares Held
94,595
-58.6% QoQ
Ownership
0.047%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CERS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026WELLS FARGO & COMPANY/MN holds $3,733,776,546 across 105 Medical Devices names. CERS ranks #56 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
15,909,341 | $1,633,412,039 | |
| 2 | SYK |
Stryker Corp
|
2,297,196 | $754,835,631 | |
| 3 | MDT |
Medtronic plc
|
7,514,778 | $651,155,511 | |
| 4 | BSX |
Boston Scientific Corp
|
2,971,322 | $186,450,453 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,081,271 | $86,588,179 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
1,150,789 | $81,913,158 | |
| 7 | DXCM |
Dexcom Inc
|
845,998 | $53,128,672 | |
| 8 | NVCR |
NovoCure Ltd
|
2,951,237 | $32,168,481 |
All Filings in CERS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $172,162 | 94,595 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $470,633 | 228,463 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $224,812 | 141,392 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $161,290 | 114,391 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $146,155 | 105,148 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $158,668 | 103,032 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $163,597 | 94,022 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $178,361 | 101,342 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $179,324 | 94,881 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $172,462 | 79,844 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $107,394 | 66,293 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $264,557 | 107,544 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $194,365 | 65,443 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $90,906 | 24,906 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $143,693 | 39,915 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $264,795 | 50,056 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $655,323 | 119,367 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,191,932 | 175,027 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $550,704 | 90,428 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $264,193 | 44,703 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,527,199 | 254,110 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,555,560 | 369,301 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $2,440,441 | 389,847 | Shares | Defined | 2020-11-05 | |
| 2020-06-30 | $2,705,227 | 409,883 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $595,296 | 128,021 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||